Call to Schedule Free Consultation at Over 80 Centers Worldwide!

(844) GET-STEM

Stem Cell Therapy for Eczema: What a Major 2025 Clinical Trial Means for Patients

Written by Dr. David Greene, MD, PhD, MBA on May 14, 2026

Table of Contents

For millions of people living with atopic dermatitis—the most common and chronic form of eczema—the daily reality involves persistent itching, inflamed skin, and the frustration of “failing” conventional treatments. When topical corticosteroids and systemic immunosuppressants provide insufficient relief or cause intolerable side effects, patients often wonder, how does stem cell therapy work for such complex conditions?

Recent advancements in regenerative medicine are shifting the landscape. A significant clinical trial published in Stem Cell Research & Therapy has highlighted the potential of Mesenchymal Stem Cells (MSCs) to modulate the immune system and repair the skin barrier from the inside out.

The Landmark South Korean Study: A Deep Dive

The study, conducted across multiple universities in South Korea, focused on 114 participants suffering from moderate-to-severe atopic dermatitis. These patients had previously seen little to no success with standard-of-care treatments, including IV biologics or oral immunosuppressants.

Study Methodology: Gold-Standard Research

To ensure the highest level of scientific integrity, the researchers employed a prospective, randomized, double-blind, placebo-controlled design. This is considered the “gold standard” in medical research because it eliminates bias. Understanding the kinds of stem cells used is crucial to evaluating these results.

Group A (Control): Received two IV infusions of saline (placebo).

Group B (Treatment): Received two IV infusions of 100 million Mesenchymal Stem Cells each, spaced one month apart.

Clinical Findings and Outcomes

The researchers utilized four distinct outcome questionnaires to measure the severity of the disease and the patients’ quality of life. The results showed statistically significant improvements at every follow-up interval over four months.

Metric

Outcome Observation

Lesion Reduction

50% of participants achieved a 50% or greater reduction in skin lesions.

Consistency

Improvements were noted across all four regions measured.

Comparison

The MSC group significantly outperformed the placebo group.

Safety Profile

No serious adverse events (SAEs) were reported.

Why Stem Cells? Addressing the Root Cause

Unlike traditional medications that merely suppress the immune system broadly, Mesenchymal Stem Cells act as “biological sensors.” In the context of atopic dermatitis, MSCs work through immunomodulation. They help regulate the overactive immune response (Th2 cytokines) responsible for the chronic inflammation seen in eczema.

Safety and Tolerability

One of the primary hurdles with systemic immunosuppressants is the side-effect profile, which can include organ toxicity or increased infection risk. When patients ask how the body reacts to stem cell injections, data from this trial offer reassurance. The stem cell group reported only minor, self-limiting issues such as:

  • Temporary headache
  • Mild dizziness

 

These symptoms resolved quickly without intervention, positioning mesenchymal stem cells as a potentially safer alternative for long-term management.

The Path Forward for Eczema Patients

This landmark study provides robust evidence that high-dose MSC therapy is not only effective but also durable over a multi-month period. For patients who have exhausted traditional pharmaceutical avenues, regenerative therapies offer a systemic approach to skin health.

Seeking Expert Care

As a leader in the field, R3 Stem Cell stays at the forefront of these clinical breakthroughs. With over 80 centers globally, including locations for stem cell therapy in Mexico, R3 provides access to advanced umbilical cord stem cell therapy designed to improve the quality of life for those struggling with chronic inflammatory conditions.

If you or a loved one is seeking an alternative to conventional eczema treatments, consider the benefits of stem cell therapy.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider to determine if regenerative medicine is right for your specific condition.

Contact Us

Stem cell therapy for diabetes is not yet a standard of care in most countries and is generally considered investigational or complementary. Patients should review FDA regulations on cell therapies for context.

Why Dr. Hector is "Passionate" About the Word "Natural"

Consent alone is not sufficient. Donor mothers also undergo comprehensive medical screening, which typically includes:

What Does the Bioethics Community Say?